Source BioScience PLC Director/PDMR Shareholding (2236C)
14 Octobre 2015 - 10:54AM
UK Regulatory
TIDMSBS
RNS Number : 2236C
Source BioScience PLC
14 October 2015
14 October 2015
Source BioScience plc
(the 'Company')
Director/PDMR Shareholding
Source BioScience plc (LSE:SBS) announces that on 12 October
2015 Laurence Turnbull, Chairman of the Company, sold 2,000,000
ordinary shares of 2 pence each in the Company ("Ordinary Shares")
in the market, at a price of 17 pence per Ordinary Share.
Following this transaction, Mr Turnbull has an interest in
2,750,000 Ordinary Shares representing approximately 0.79% of the
Company's issued share capital.
This notification is provided in accordance with
DTR3.1.4R(1).
--- ENDS ---
For further information, please contact:
Source BioScience plc
Dr Nick Ash, CEO and Company Secretary
Tel: +44 (0)115 973 9010
Email: enquiries@sourcebioscience.com
www.sourcebioscience.com
N+1 Singer (Financial Advisor, Sponsor and Broker)
Aubrey Powell/James White
Tel: +44 (0)207 496 3000
www.n1singer.com
About Source BioScience
Source BioScience plc (LSE: SBS) is a trusted provider of state
of the art laboratory services and products to the healthcare and
clinical, life and applied sciences and biopharma industries. It is
an international business operating ten state of the art facilities
in five countries and with customers in over 90 countries
worldwide. The Group offers a complementary portfolio of laboratory
services and products that share common technologies, laboratory
processes, infrastructure and expertise. These include clinical
diagnostics, genomics, proteomics, drug discovery and development
research as well as controlled environment storage and testing
services for a diverse range of markets. These services and
products are provided to a large and diverse customer base
including the top 50 pharmaceutical companies, leading universities
and research institutes worldwide, the UK NHS and other healthcare
providers. The Group is listed on the Premium Main Market of the
London Stock Exchange.
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSFFDSALFISEIS
(END) Dow Jones Newswires
October 14, 2015 04:54 ET (08:54 GMT)
Medical Solutions (LSE:MLS)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024
Medical Solutions (LSE:MLS)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024